A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients (PACIFICO)
Purine-Alkylator Combination In Follicular Lymphoma Immuno-Chemotherapy for Older Patients: a Phase III Comparison of First-line R-CVP Versus R-FC
Sponsor: Cancer Research UK
This PHASE3 trial investigates Follicular Lymphoma and is currently completed. Cancer Research UK leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
May 2025 — Sep 2025 [monthly]
Completed PHASE3
Status: Unknown → Completed
-
Sep 2024 — May 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
▶ Show 3 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Feb 2020 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Oct 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Research UK
- Liverpool University Hospitals NHS Foundation Trust
- Roche Pharma AG
- University of Liverpool
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aberdeen, United Kingdom , Bangor, United Kingdom , Birmingham, United Kingdom , Bournemouth, United Kingdom , Bradford, United Kingdom , Bristol, United Kingdom , Burton-on-Trent, United Kingdom , Cambridge, United Kingdom , Canterbury, United Kingdom , Cardiff, United Kingdom and 54 more locations